-
Fujifilm Pharma's liposomal formulation of gemcitabine FF─10832 receives US FDA's orphan drug designation to treat biliary tract cancer
09 Jul 2025 11:50 GMT
… Drug Administration (FDA) has granted orphan drug … and slow clinical trials, stalling progress … new and effective treatments.
Gemcitabine has been … treatment options,” said Susumu Shimoyama, president, Fujifilm Pharmaceuticals USA, Inc. “Receiving orphan drug …
-
Immuneering Granted U.S. Composition of Matter Patent for Highly Differentiated Cancer Drug Candidate Atebimetinib
09 Jul 2025 12:00 GMT
… to compounds, pharmaceutical compositions, … FDA also previously granted atebimetinib orphan drug designation for the treatment … Gemcitabine/nab-paclitaxel (mGnP) in first-line pancreatic cancer; the treatment … atebimetinib combination trials; the expected …
-
6 AIIMS Bhopal doctors resign over Administrative lapses
09 Jul 2025 11:00 GMT
… neonatology. Of the six, three doctors were from the oncology department … of medicines.
One major concern was the cost of Gemcitabine, a cancer drug … should retain the top medical experts. Top doctors are leaving, and it …
-
Drug Combo Outpaces Standard Chemo in R/R LBCL
09 Jul 2025 06:13 GMT
… 8 months for the rituximab-gemcitabine-oxaliplatin (R-GemOx) regimen … (Lunsumio), which is FDA-approved for patients with … medicines, we hoped to build upon the success of these drugs … the SUNMO trial, noted that the current treatment landscape is …
-
FDA Grants Orphan Drug Designation to Liposomal Gemcitabine in Biliary Tract Cancer
08 Jul 2025 22:50 GMT
… trials for a disease with limited current therapies.
The FDA … gemcitabine, for the treatment of BTC. This designation underscores the critical unmet medical … Pharmaceuticals’ investigational drug … trial data emerges. The strategic benefit of enhanced drug …
-
FDA Grants Orphan Drug Designation to FF-10832 for Biliary Tract Cancer
08 Jul 2025 19:48 GMT
… of gemcitabine—for the treatment of … treatment options,” Susumu Shimoyama, president of FUJIFILM Pharmaceuticals … drug designation highlights the significant unmet medical … trial (NCT05318573).3
FF-10832 granted FDA orphan drug designation for the treatment …
-
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies
08 Jul 2025 12:50 GMT
… and controlled trials.” Active oncology biotech and … and Drug Administration (“FDA”) has granted Orphan Drug Designation … with gemcitabine and cisplatin as neoadjuvant treatment, followed … trial, which were published in The New England Journal of Medicine …
-
Dr Lotan on Guideline-Supported Treatment Decision-Making for NMIBC
08 Jul 2025 02:41 GMT
… well as the medical director of the … additional intravesical or systemic treatment attempts reasonable, according … Intravesical gemcitabine and docetaxel, though lacking prospective trial data, … added. Furthermore, clinical trials remain a vital consideration …
-
Bispecific Antibody Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
07 Jul 2025 17:00 GMT
… FDA-approved bispecific antibody list @ Bispecific Antibody Drugs … combination with gemcitabine and oxaliplatin … Medicine
5.
Bispecific Antibody Clinical Trial … Pharmaceuticals, Kecellitics Biotech Company, Yake Biotechnology, Minerva Biotechnologies, …
-
FF-10832 Granted FDA Orphan Drug Designation for the Treatment of Biliary Tract Cancer
07 Jul 2025 15:14 GMT
… treatment of solid tumors in the U.S.
The FDA grants orphan drug … new and effective treatments.
Gemcitabine has been a … .
About FUJIFILM
FUJIFILM Pharmaceuticals U.S.A., … medical institutions, academic partners, and industry partners to conduct clinical trials …